Antibody Drug Conjugates (ADCs) |
Formosa Laboratories (Formosa Labs) provides one-stop solution for Antibody-Drug Conjugates (ADCs) manufacturing from antibody production through domestic alliance, to in-house toxin-linker CMC services and antibody bioconjugation for drug substance (DS), and finally through to cytotoxic fill-finish drug product (DP) manufacturing. To demonstrate our capability, Formosa Labs is developing a biosimilar of ado-trastuzumab emtansine (biosimilar Kadcyla), which is available for co-development or out-licensing.

Integrated ADC CMC Service

|
|
|